mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN)

Gut

Volumn 63, Issue 10, 2014, Pages 1626-1634

  Das, Koushik K ^a   Xiao, Hong ^a   Geng, Xin ^b   Fernandez del Castillo, Carlos ^a   Morales Oyarvide, Vicente ^a   Daglilar, Ebubekir ^a   Forcione, David G ^a   Bounds, Brenna C ^a   Brugge, William R ^a   Pitman, Martha B ^a   Mino Kenudson, Mari ^a   Das, Kiron M ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLON EPITHELIAL PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DAS 1; TUMOR MARKER; UNCLASSIFIED DRUG; ANTIBODY; DAS 1 PROTEIN, HUMAN; DAS-1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYST FLUID; CYSTIC NEOPLASM; DYSPLASIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; PANCREAS PSEUDOCYST; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING; ANTIBODY SPECIFICITY; COLLOID CARCINOMA; IMMUNOLOGY; MIDDLE AGED; PANCREAS CANCER; PANCREAS CARCINOMA; PANCREAS TUMOR; PANCREATIC PATHOLOGY; PANCREATIC TUMOURS; PAPILLARY CARCINOMA;

PANCREATIC CANCER; PANCREATIC PATHOLOGY; PANCREATIC TUMOURS;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANTIBODIES; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84908508248     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-306219     Document Type: Article

References (44)

1. Hruban RH, Pitman MB, Klimstra DS. Intraductal neoplasms. In: Hruban RH, Pitman MB, Klimstra DS, eds. Tumors of the Pancreas. Washington, DC: American Registry of Pathology, 2007:75-110.
2. Ohashi K, Murakami Y, Maruyama M. Four cases of mucin-producing cancer of the pancreas on specific findings of the papilla of Vater. Prog Dig Endoscopy 1982;20:348-52.
3. Farrell JJ, Brugge WR. Intraductal papillary mucinous tumor of the pancreas. Gastrointest Endosc 2002;55:701-14.
4. Laffan TA, Horton KM, Klein AP, et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol 2008;191:802-7.
5. Crippa S, Fernandez-Del Castillo C, Salvia R, et al. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol 2010;8:213-19.
6. Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004;239:678-85; discussion 685-7.
7. Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002;123:1500-7.
8. Maire F, Hammel P, Terris B, et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 2002;51:717-22.
9. Raimondo M, Tachibana I, Urrutia R, et al. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 2002;97:2553-8.
10. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal Papillary Mucinous Neoplasms of the Pancreas. Annals of Surgery 2004;239:788-99.
11. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17-32.
12. Nagai K, Doi R, Ito T, et al. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg 2009;16:353-8.
13. Tang RS, Weinberg B, Dawson DW, et al. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol 2008;6:815-19; quiz 719.
14. Pelaez-Luna M, Chari ST, Smyrk TC, et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol 2007;102:1759-64.
15. Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12:183-97.
16. Ono J, Yaeger KA, Genevay M, et al. Cytological analysis of small branch-duct intraductal papillary mucinous neoplasms provides a more accurate risk assessment of malignancy than symptoms. Cytojournal 2011;8:21.
17. Bausch D, Mino-Kenudson M, Fernandez-Del Castillo C, et al. Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms. J Gastrointest Surg 2009;13:1948-54; discussion 1954.
18. Khalid A, Zahid M, Finkelstein SD, et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009;69:1095-102.
19. Furukawa T, Kloppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005;447:794-9.
20. Adsay NV, Adair CF, Heffess CS, et al. Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol 1996;20:980-94.
21. Adsay NV, Pierson C, Sarkar F, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 2001;25:26-42.
22. Fernandez-del Castillo C, Adsay NV. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 2010;139:708-13, 713 e1-2.
23. Das KM, Sakamaki S, Vecchi M, et al. The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody. J Immunol 1987;139:77-84.
24. Halstensen TS, Das KM, Brandtzaeg P. Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis. Gut 1993;34:650-7.
25. Das KM, Prasad I, Garla S, et al. Detection of a shared colon epithelial epitope on Barrett epithelium by a novel monoclonal antibody. Ann Intern Med 1994;120:753-6.
26. Mirza ZK, Das KK, Slate J, et al. Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma. Gut 2003;52:807-12.
27. Piazuelo MB, Haque S, Delgado A, et al. Phenotypic differences between esophageal and gastric intestinal metaplasia. Mod Pathol 2004;17:62-74.
28. Griffel LH, Amenta PS, Das KM. Use of a novel monoclonal antibody in diagnosis of Barrett's esophagus. Dig Dis Sci 2000;45:40-8.
29. Watari J, Moriichi K, Tanabe H, et al. Biomarkers predicting development of metachronous gastric cancer after endoscopic resection: an analysis of molecular pathology of Helicobacter pylori eradication. Int J Cancer 2012;130:2349-58.
30. Kesari KV, Yoshizaki N, Geng X, et al. Externalization of tropomyosin isoform 5 in colon epithelial cells. Clin Exp Immunol 1999;118:219-27.
31. Bajpai M, Liu J, Geng X, et al. Repeated exposure to acid and bile selectively induces colonic phenotype expression in a heterogeneous Barrett's epithelial cell line. Lab Invest 2008;88:643-51.
32. Taniguchi M, Geng X, Liu J, et al. Structural diversity in the epitope shared by colon epithelium and extracolonic organs commonly involved in ulcerative colitis: Molecular analysis using monoclonal antibodies. Gastroenterology 2001;120:A353.
33. Al-Rashdan A, Schmidt CM, Al-Haddad M, et al. Fluid analysis prior to surgical resection of suspected mucinous pancreatic cysts. A single centre experience. J Gastrointest Oncol 2011;2:208-14.
34. Badve S, Logdberg L, Sokhi R, et al. An antigen reacting with das-1 monoclonal antibody is ontogenically regulated in diverse organs including liver and indicates sharing of developmental mechanisms among cell lineages. Pathobiology 2000;68:76-86.
35. Onuma EK, Amenta PS, Jukkola AF, et al. A phenotypic change of small intestinal epithelium to colonocytes in small intestinal adenomas and adenocarcinomas. Am J Gastroenterol 2001;96:2480-5.
36. Pantuck AJ, Murphy DP, Amenta PS, et al. The monoclonal antibody 7E12H12 can differentiate primary adenocarcinoma of the bladder and prostate. Br J Urol 1998;82:426-30.
37. Mino-Kenudson M, Fernandez-Del Castillo C, Baba Y, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut 2011;60:1712-20.
38. Ishida M, Egawa S, Aoki T, et al. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Pancreas 2007;35:348-52.
39. Sawai Y, Yamao K, Bhatia V, et al. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy 2010;42:1077-84.
40. Matthaei H, Wylie D, Lloyd MB, et al. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res 2012;18:4713-24.
41. Kanda M, Knight S, Topazian M, et al. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut 2013;62:1024-33.
42. Kanda M, Sadakari Y, Borges M, et al. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol 2013;11:719-30, e5.
43. Genevay M, Mino-Kenudson M, Yaeger K, et al. Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts. Ann Surg 2011;254:977-83.
44. Maker AV, Lee LS, Raut CP, et al. Cytology from Pancreatic Cysts Has Marginal Utility in Surgical Decision-Making. Ann Surg Oncol 2008;15:3187-92.